Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News! 22 Jahre "BlueChip"-Power nun bei NurExone!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
37 Leser
Artikel bewerten:
(0)

North America Feed Antibiotics Market (2015-2020) - Expected to Reach $849.3 Million by 2020

DUBLIN, Feb. 29, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/r2xdrz/north_america) has announced the addition of the "North America Feed Antibiotics market - Growth, Trends And Forecasts (2015-2020)" report to their offering.

The North American Feed antibiotics market is $761.3 million in 2015 and is expected to reach a value $849.3 million by 2020 with a CAGR of 2.2%.

Feed antibiotics which have playing the major role in North America because the meat production industry have witnessed a slow down due to rising consumer awareness regarding hazards of residue in the meat. These are important ingredients that are combined with basic feed mix to prevent animal diseases and improve their overall growth. All these benefits of antibiotics have driven the growth of the market in the region.

But the recent developments suggesting that some bacteria have become resistant to more than one type of antibiotic, which makes it more difficult to treat the infections they cause has led to the ban of certain substances in few markets. This has called for the judicious use of antibiotics and in expert recommended quantities to preserve their effectiveness for better human and animal health.

North America is the second largest market in the Feed Antibiotics market.

Key Topics Covered:

1. Introduction

2. Key Findings of the Study

3. Market Overview

4. Market Segmentation

5. Competitive Landscape - Feed Additives

6. Company Profiles

  • Abbott Laboratories
  • Bayer HealthCare AG
  • Bristol-Myers Squibb Co.
  • Cubist Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Limited
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • LG Life Sciences Limited
  • Novartis AG
  • Pfizer Inc.
  • Roche
  • Sanofi-Aventis SA
  • Takeda Pharmaceutical Company, Ltd.

For more information visit http://www.researchandmarkets.com/research/r2xdrz/north_america

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.